Doximity, Inc. announced that its HIPAA-compliant clinical AI platform, Doximity Ask, outperformed leading frontier AI models in the NOHARM benchmark. This independent evaluation of clinical AI safety was conducted by ARISE, a clinical AI research team led by physicians from Stanford and Harvard Medical Schools. The study assessed how AI models handle simulated patient cases to determine their safety and reliability in medical settings.

Doximity Ask ranked first among all AI systems evaluated on the study's real-world clinical sample, which mirrors how physicians use these tools in practice. Purpose-built clinical AI systems outperformed general-purpose frontier models across the broader automated evaluation. The benchmark included automated testing across more than 1,100 scenarios spanning 10 medical specialties and was developed by over 50 researchers with contributions from 29 board-certified physicians.

Performance Drivers

Doximity attributes its performance to the platform's design, which is built specifically for clinical workflows. The company emphasized that its results stem from investment in physician authorship at scale. Through its PeerCheck program, more than 11,000 cited physician experts have evaluated and improved Doximity Ask outputs.

"We have long believed that the path to trustworthy healthcare AI runs through physicians, not around them," said Dr. Louis-Antoine Mullie, Head of Medical AI at Doximity. "Continuous physician review isn't a differentiator. It's a requirement. This result reinforces the importance of combining advanced AI systems with rigorous clinical oversight and independent safety evaluations like NOHARM."

Deployment and Security

Doximity's Clinical AI Suite, including Ask, has been deployed across more than 150 health systems, including eight of the nation's top 20 hospitals. The platform incorporates end-to-end encryption, role-based access controls, audit logging, and session isolation. These features are designed to help healthcare organizations deploy AI while maintaining enterprise-grade security and privacy standards.

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Doximity Inc. breached their fiduciary duties to shareholders. The investigation, announced on July 3, 2026, seeks to determine if the company's leadership failed to act in the best interests of its investors. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation, with the firm handling matters on a contingent fee basis.

The law firm represents investors globally who have been victims of securities fraud and corporate misconduct. Halper Sadeh LLC aims to help improve company policies, practices, and oversight mechanisms to create a more transparent and accountable organization. Shareholders who currently own Doximity stock and are long-term holders may be able to seek corporate governance reforms, the return of funds to the company, or a court-approved financial incentive award.

Investors should contact the firm immediately as there may be limited time to enforce their rights. The attorneys at Halper Sadeh LLC have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. The firm is headquartered at One World Trade Center, 85th Floor, New York, NY 10007.

The investigation follows recent concerns regarding Doximity's financial performance and strategic direction. Shareholders are advised to review their legal options promptly to ensure their rights are protected.